Surgical Treatment for Obesity and Its Impact on Non-alcoholic Steatohepatitis

Clinics in Liver Disease

Volumn 11, Issue 1, 2007, Pages 141-154

  Dixon, John B ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ATHEROSCLEROSIS; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CLINICAL FEATURE; COMORBIDITY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FIBRINOLYSIS; FOLLOW UP; GASTRIC BANDING; GASTROPLASTY; HUMAN; HYPERTENSION; INSULIN RESISTANCE; JEJUNOILEAL BYPASS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NUTRITIONAL ASSESSMENT; OBESITY; OVARY POLYCYSTIC DISEASE; PHYSICAL ACTIVITY; POSTOPERATIVE COMPLICATION; REVIEW; ROUX Y ANASTOMOSIS; SLEEP APNEA SYNDROME; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT REDUCTION;

BARIATRIC SURGERY; FATTY LIVER; HEPATITIS; HUMANS; OBESITY; WEIGHT LOSS;

EID: 34249733066     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2007.02.005     Document Type: Review

References (61)

1. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 23 (2004) 2847-2850
2. Clark J.M., Brancati F.L., and Diehl A.M. Nonalcoholic fatty liver disease. Gastroenterology 122 6 (2002) 1649-1657
3. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 6865 (2001) 782-787
4. Dixon J.B., Bhathal P.S., and O'Brien P.E. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 121 1 (2001) 91-100
5. Marchesini G., Bugianesi E., Forlani G., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 4 (2003) 917-923
6. Marceau P., Biron S., Hould F.S., et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84 5 (1999) 1513-1517
7. Hamaguchi M., Kojima T., Takeda N., et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med 143 10 (2005) 722-728
8. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 6 (1999) 1413-1419
9. Day C.P., and James O.F. Hepatic steatosis: innocent bystander or guilty party?. Hepatology 27 6 (1998) 1463-1466
10. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 9491 (2005) 1059-1062
11. Buchwald H., and Williams S.E. Bariatric surgery worldwide 2003. Obes Surg 14 9 (2004) 1157-1164
12. Tsai A.G., and Wadden T.A. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med 142 1 (2005) 56-66
13. Li Z., Maglione M., Tu W., et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 142 7 (2005) 532-546
14. Schwartz M.W., Woods S.C., Seeley R.J., et al. Is the energy homeostasis system inherently biased toward weight gain?. Diabetes 52 2 (2003) 232-238
15. Dixon A.F., Dixon J.B., and O'Brien P.E. Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. J Clin Endocrinol Metab 90 2 (2005) 813-819
16. Small C.J., and Bloom S.R. Gut hormones and the control of appetite. Trends Endocrinol Metab 15 6 (2004) 259-263
17. Chapman A., Kiroff G., Game P., et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic review. Surgery 135 (2004) 326-351
18. Buchwald H., Avidor Y., Braunwald E., et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 292 14 (2004) 1724-1737
19. Maggard M.A., Shugarman L.R., Suttorp M., et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 142 7 (2005) 547-559
20. MLF. Height and weight tables: metropolitan life foundation (1983), Metropolitan Life Insurance Company, New York
21. O'Brien P.E., Dixon J.B., and Brown W. Obesity is a surgical disease: overview of obesity and bariatric surgery. ANZ J Surg 74 4 (2004) 200-204
22. Dixon J.B., Anderson M., Cameron-Smith D., et al. Sustained weight loss in obese subjects has benefits that are independent of attained weight. Obes Res 12 11 (2004) 1895-1902
23. Dixon J.B., Dixon A.F., and O'Brien P.E. Improvements in insulin sensitivity and beta-cell function (HOMA) with weight loss in the severely obese. Diabet Med 20 2 (2003) 127-134
24. Dixon J.B., and O'Brien P. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 25 2 (2002) 358-363
25. Pories W.J., Swanson M.S., MacDonald K.G., et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222 3 (1995) 339-350 [discussion 350-2]
26. Schauer P., Burguera B., Ikramuddin S., et al. Effect of laparoscopic roux-en Y gastric bypass on type 2 diabetes mellitis. Ann Surg 238 (2003) 467-485
27. Dixon J.B., and O'Brien P.E. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 184 6B (2002) S51-S54
28. Dixon J.B., Schachter L.M., and O'Brien P.E. Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int J Obes Relat Metab Disord 29 9 (2005) 1048-1054
29. Dixon J.B., and O'Brien P.E. Neck circumference a good predictor of raised insulin and free androgen index in obese premenopausal women: changes with weight loss. Clin Endocrinol (Oxf) 57 6 (2002) 769-778
30. Dixon J.B., Dixon M.E., and O'Brien P.E. Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res 9 11 (2001) 713-721
31. Dixon J.B., Dixon M.E., and O'Brien P.E. Body image: appearance orientation and evaluation in the severely obese. Changes with weight loss. Obes Surg 12 1 (2002) 65-71
32. Dixon J.B., Dixon M.E., and O'Brien P.E. Depression in association with severe obesity: changes with weight loss. Arch Intern Med 163 17 (2003) 2058-2065
33. Flum D.R., and Dellinger E.P. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg 199 4 (2004) 543-551
34. Christou N.V., Sampalis J.S., Liberman M., et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 240 3 (2004) 416-423
35. DeWind L.T., and Payne J.H. Intestinal bypass surgery for morbid obesity. Long-term results. JAMA 236 20 (1976) 2298-2301
36. Rucker Jr. R.D., Horstmann J., Schneider P.D., et al. Comparisons between jejunoileal and gastric bypass operations for morbid obesity. Surgery 92 2 (1982) 241-249
37. Hocking M.P., Davis G.L., Franzini D.A., et al. Long-term consequences after jejunoileal bypass for morbid obesity. Dig Dis Sci 43 11 (1998) 2493-2499
38. O'Leary J.P. Hepatic complications of jejunoileal bypass. Semin Liver Dis 3 3 (1983) 203-215
39. Antal S.C. Prevention and reversal of liver damage following biliopancreatic diversion for obesity. Obes Surg 4 3 (1994) 285-290
40. Castillo J., Fabrega E., Escalante C.F., et al. Liver transplantation in a case of steatohepatitis and subacute hepatic failure after biliopancreatic diversion for morbid obesity. Obes Surg 11 5 (2001) 640-642
41. Kral J.G., Thung S.N., Biron S., et al. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 135 1 (2004) 48-58
42. Mason E.E., Printen K.J., Blommers T.J., et al. Gastric bypass for obesity after ten years experience. Int J Obes 2 2 (1978) 197-206
43. Ranlov I., and Hardt F. Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 47 4 (1990) 208-214
44. Silverman E.M., Sapala J.A., and Appelman H.D. Regression of hepatic steatosis in morbidly obese persons after gastric bypass. Am J Clin Pathol 104 1 (1995) 23-31
45. Mattar S.G., Velcum L.M., Rabinovitz M., et al. Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Ann Surg 242 4 (2005) 610-617
46. Clark J.M., Alkhuraishi A.R., Solga S.F., et al. Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obes Res 13 7 (2005) 1180-1186
47. de Almeida S.R., Rocha P.R., Sanches M.D., et al. Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obes Surg 16 3 (2006) 270-278
48. Dallal R.M., Mattar S.G., Lord J.L., et al. Results of laparoscopic gastric bypass in patients with cirrhosis. Obes Surg 14 1 (2004) 47-53
49. Duchini A., and Brunson M.E. Roux-en-Y gastric bypass for recurrent nonalcoholic steatohepatitis in liver transplant recipients with morbid obesity. Transplantation 72 1 (2001) 156-159
50. Luyckx F.H., Desaive C., Thiry A., et al. Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 22 3 (1998) 222-226
51. Stratopoulos C., Papakonstantinou A., Terzis I., et al. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 15 8 (2005) 1154-1160
52. Jaskiewicz K., Raczynska S., Rzepko R., et al. Nonalcoholic fatty liver disease treated by gastroplasty. Dig Dis Sci 51 1 (2006) 21-26
53. Neuschwander-Tetri B.A., and Caldwell S.H. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37 5 (2003) 1202-1219
54. Neuschwander-Tetri B.A., Brunt E.M., Wehmeier K.R., et al. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone. Hepatology 38 4 (2003) 1008-1017
55. Dixon J.B., Bhathal P.S., Hughes N.R., et al. Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 39 6 (2004) 1647-1654
56. Friis R., Vaziri N.D., Akbarpour F., et al. Effect of rapid weight loss with supplemented fasting on liver tests. J Clin Gastroenterol 9 2 (1987) 204-207
57. Andersen T. Liver and gallbladder disease before and after very-low-calorie diets. Am J Clin Nutr 56 1 Suppl (1992) 235S-239S
58. Andersen T., Gluud C., Franzmann M.B., et al. Hepatic effects of dietary weight loss in morbidly obese subjects. J Hepatol 12 2 (1991) 224-229
59. Fielding G.A., and Allen J.W. A step-by-step guide to placement of the LAP-BAND adjustable gastric banding system. Am J Surg 184 6B (2002) 26S-30S
60. Brolin R.E., Gorman R.C., Milgrim L.M., et al. Multivitamin prophylaxis in prevention of post-gastric bypass vitamin and mineral deficiencies. Int J Obes 15 10 (1991) 661-667
61. Hickman I.J., Jonsson J.R., Prins J.B., et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 53 3 (2004) 413-419